BioSpace News Archive

Availability of advanced immunofluorescence assays kits and reagents, growing healthcare burden of chronic diseases, and increasing investments in healthcare sector are key factors driving market growth.

NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 fourth quarter and full year financial results before the opening of the market on January 27, 2022.

Increasing research and development activities, growing implementation of precision medicine, and surging preference for multiplex assays over conventional assays are some of the key factors driving global market revenue growth.

Medline today announced that it has been awarded a five-year cooperative agreement with OMNIA Partners, one of the nation’s largest purchasing organizations for public and private sector procurement. In effect as of November 1, 2021, the publicly solicited contract is available nationwide.

Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will host a key opinion leader (KOL) webinar on hematological malignancies and prostate cancer on Tuesday, January 25, 2022 from 2:30 - 4:30 pm (ET).

Schrödinger, Inc., whose physics-based software platform is transforming the way therapeutics and materials are discovered, reported that on January 16, 2022, the company granted non-statutory stock options to purchase an aggregate of 80,675 shares of the company’s common stock to 80 newly hired employees, including 77 newly hired employees based in India.

Geron Corporation reported that it has granted non-statutory stock options to purchase an aggregate of 435,800 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

Medical waste is waste generated from healthcare and medical facilities. The release of biological hazards and chemical gases into environment can have disastrous effects on the wellbeing and health of general population.

Increasing adoption of robotic assisted surgery is anticipated to fuel the demand in the global cervical cancer endoscopic devices market in coming years.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR, due to increased technological improvements in the healthcare sector, the global computer-assisted orthopedic surgery market is expected to grow at a CAGR of 5.5% over the projected period 2021-2031.